Cite
Exosomal miR-625-3p secreted by cancer-associated fibroblasts in colorectal cancer promotes EMT and chemotherapeutic resistance by blocking the CELF2/WWOX pathway.
MLA
Zhang, Ying, et al. “Exosomal MiR-625-3p Secreted by Cancer-Associated Fibroblasts in Colorectal Cancer Promotes EMT and Chemotherapeutic Resistance by Blocking the CELF2/WWOX Pathway.” Pharmacological Research, vol. 186, Dec. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.phrs.2022.106534.
APA
Zhang, Y., Yin, C., Wei, C., Xia, S., Qiao, Z., Zhang, X.-W., Yu, B., Zhou, J., & Wang, R. (2022). Exosomal miR-625-3p secreted by cancer-associated fibroblasts in colorectal cancer promotes EMT and chemotherapeutic resistance by blocking the CELF2/WWOX pathway. Pharmacological Research, 186, N.PAG. https://doi.org/10.1016/j.phrs.2022.106534
Chicago
Zhang, Ying, Changjun Yin, Chao Wei, Shuai Xia, Zhu Qiao, Xue-Wen Zhang, Bin Yu, Jun Zhou, and Rong Wang. 2022. “Exosomal MiR-625-3p Secreted by Cancer-Associated Fibroblasts in Colorectal Cancer Promotes EMT and Chemotherapeutic Resistance by Blocking the CELF2/WWOX Pathway.” Pharmacological Research 186 (December): N.PAG. doi:10.1016/j.phrs.2022.106534.